These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19139203)

  • 21. Effects of stress on inflammatory autoimmune disease: destructive or protective?
    Jessop DS; Richards LJ; Harbuz MS
    Stress; 2004 Dec; 7(4):261-6. PubMed ID: 16019592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune-mediated inflammatory disorders (I.M.I.D.s): the economic and clinical costs.
    Williams JP; Meyers JA
    Am J Manag Care; 2002 Dec; 8(21 Suppl):S664-81; quiz S682-5. PubMed ID: 12516953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent topics in histopathology associated with joint destruction in rheumatoid arthritis].
    Sawai T; Uzuki M
    Clin Calcium; 2009 Mar; 19(3):325-38. PubMed ID: 19252242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis.
    Dawczynski C; Schubert R; Hein G; Müller A; Eidner T; Vogelsang H; Basu S; Jahreis G
    Br J Nutr; 2009 May; 101(10):1517-26. PubMed ID: 19245735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.
    Clapp C; Adán N; Ledesma-Colunga MG; Solís-Gutiérrez M; Triebel J; Martínez de la Escalera G
    Cell Mol Life Sci; 2016 Aug; 73(15):2929-48. PubMed ID: 27026299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Joint destruction and its repair in rheumatoid arthritis].
    Kohsaka H
    Clin Calcium; 2009 Mar; 19(3):317-23. PubMed ID: 19252241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathological changes in the arterial bed in chronic inflammatory joint diseases and their relationship to the focus of chronic inflammation and to bone necroses].
    Fricke R; Wagner HH
    Verh Dtsch Ges Rheumatol; 1976; 4():335-40. PubMed ID: 997805
    [No Abstract]   [Full Text] [Related]  

  • 29. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis.
    van Roon JA; Lafeber FP; Bijlsma JW
    Arthritis Rheum; 2001 Jan; 44(1):3-12. PubMed ID: 11212172
    [No Abstract]   [Full Text] [Related]  

  • 30. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathoetiology of chronic rheumatoid arthritis--from inflammation to bone destruction. 2) From the viewpoint of immunology].
    Sumida T
    Nihon Naika Gakkai Zasshi; 2000 Oct; 89(10):2064-71. PubMed ID: 11215118
    [No Abstract]   [Full Text] [Related]  

  • 32. Vascular disease in rheumatoid arthritis: from subclinical lesions to cardiovascular risk.
    Tanasescu C; Jurcut C; Jurcut R; Ginghina C
    Eur J Intern Med; 2009 Jul; 20(4):348-54. PubMed ID: 19524171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinician's comment on the management of pain in arthritis.
    Pisetsky DS
    Health Psychol; 2007 Nov; 26(6):657-9. PubMed ID: 18020835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of physical training of rheumatic patients.
    Suwalska M
    Ann Clin Res; 1982; 14 Suppl 34():107-9. PubMed ID: 7149618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The pathogenesis of inflammatory joint diseases with special emphasis on the pain and inflammation mediators].
    Müller-Fassbender H
    Wien Med Wochenschr; 1980; 130 Spec No():1-6. PubMed ID: 6450486
    [No Abstract]   [Full Text] [Related]  

  • 36. Pan-DR-binding Hsp60 self epitopes induce an interleukin-10-mediated immune response in rheumatoid arthritis.
    de Jong H; Lafeber FF; de Jager W; Haverkamp MH; Kuis W; Bijlsma JW; Prakken BJ; Albani S
    Arthritis Rheum; 2009 Jul; 60(7):1966-76. PubMed ID: 19565483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory cells and bone loss in rheumatoid arthritis.
    Haynes DR
    Arthritis Res Ther; 2007; 9(3):104. PubMed ID: 17601357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
    Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
    J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid arthritis.
    Charles J; Britt H; Pan Y
    Aust Fam Physician; 2013 Nov; 42(11):765. PubMed ID: 24217093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system.
    van den Oever IA; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2014 Jun; 73(6):954-7. PubMed ID: 24431395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.